As such, we treated mice undergoing experimental colitis (both DSS colitis and infectious colitis) with the NAD+ precursor, NR, and assessed the effects of NR treatment on the SIRT1-PGC1α axis. This evidence concerns the gene PPARGC1A and infectious colitis.